Copyright Reports & Markets. All rights reserved.

Global Neisseria meningitidis Infections Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Neisseria meningitidis Infections Drug

      • 1.1 Definition of Neisseria meningitidis Infections Drug
      • 1.2 Neisseria meningitidis Infections Drug Segment by Type
        • 1.2.1 Global Neisseria meningitidis Infections Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 MGBBP-3
        • 1.2.3 NCL-195
        • 1.2.4 TP-10
        • 1.2.5 Others
      • 1.3 Neisseria meningitidis Infections Drug Segment by Applications
        • 1.3.1 Global Neisseria meningitidis Infections Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Neisseria meningitidis Infections Drug Overall Market
        • 1.4.1 Global Neisseria meningitidis Infections Drug Revenue (2014-2025)
        • 1.4.2 Global Neisseria meningitidis Infections Drug Production (2014-2025)
        • 1.4.3 North America Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
        • 1.4.5 China Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)
        • 1.4.8 India Neisseria meningitidis Infections Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Neisseria meningitidis Infections Drug
      • 2.3 Manufacturing Process Analysis of Neisseria meningitidis Infections Drug
      • 2.4 Industry Chain Structure of Neisseria meningitidis Infections Drug

      3 Development and Manufacturing Plants Analysis of Neisseria meningitidis Infections Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Neisseria meningitidis Infections Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Neisseria meningitidis Infections Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Neisseria meningitidis Infections Drug Production and Capacity Analysis
      • 4.2 Neisseria meningitidis Infections Drug Revenue Analysis
      • 4.3 Neisseria meningitidis Infections Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Neisseria meningitidis Infections Drug Regional Market Analysis

      • 5.1 Neisseria meningitidis Infections Drug Production by Regions
        • 5.1.1 Global Neisseria meningitidis Infections Drug Production by Regions
        • 5.1.2 Global Neisseria meningitidis Infections Drug Revenue by Regions
      • 5.2 Neisseria meningitidis Infections Drug Consumption by Regions
      • 5.3 North America Neisseria meningitidis Infections Drug Market Analysis
        • 5.3.1 North America Neisseria meningitidis Infections Drug Production
        • 5.3.2 North America Neisseria meningitidis Infections Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Neisseria meningitidis Infections Drug Import and Export
      • 5.4 Europe Neisseria meningitidis Infections Drug Market Analysis
        • 5.4.1 Europe Neisseria meningitidis Infections Drug Production
        • 5.4.2 Europe Neisseria meningitidis Infections Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Neisseria meningitidis Infections Drug Import and Export
      • 5.5 China Neisseria meningitidis Infections Drug Market Analysis
        • 5.5.1 China Neisseria meningitidis Infections Drug Production
        • 5.5.2 China Neisseria meningitidis Infections Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Neisseria meningitidis Infections Drug Import and Export
      • 5.6 Japan Neisseria meningitidis Infections Drug Market Analysis
        • 5.6.1 Japan Neisseria meningitidis Infections Drug Production
        • 5.6.2 Japan Neisseria meningitidis Infections Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Neisseria meningitidis Infections Drug Import and Export
      • 5.7 Southeast Asia Neisseria meningitidis Infections Drug Market Analysis
        • 5.7.1 Southeast Asia Neisseria meningitidis Infections Drug Production
        • 5.7.2 Southeast Asia Neisseria meningitidis Infections Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Neisseria meningitidis Infections Drug Import and Export
      • 5.8 India Neisseria meningitidis Infections Drug Market Analysis
        • 5.8.1 India Neisseria meningitidis Infections Drug Production
        • 5.8.2 India Neisseria meningitidis Infections Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Neisseria meningitidis Infections Drug Import and Export

      6 Neisseria meningitidis Infections Drug Segment Market Analysis (by Type)

      • 6.1 Global Neisseria meningitidis Infections Drug Production by Type
      • 6.2 Global Neisseria meningitidis Infections Drug Revenue by Type
      • 6.3 Neisseria meningitidis Infections Drug Price by Type

      7 Neisseria meningitidis Infections Drug Segment Market Analysis (by Application)

      • 7.1 Global Neisseria meningitidis Infections Drug Consumption by Application
      • 7.2 Global Neisseria meningitidis Infections Drug Consumption Market Share by Application (2014-2019)

      8 Neisseria meningitidis Infections Drug Major Manufacturers Analysis

      • 8.1 Beijing Minhai Biotechnology Co Ltd
        • 8.1.1 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.1.2 Beijing Minhai Biotechnology Co Ltd Product Introduction, Application and Specification
        • 8.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Biological E Ltd
        • 8.2.1 Biological E Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.2.2 Biological E Ltd Product Introduction, Application and Specification
        • 8.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 China National Pharmaceutical Group Corp
        • 8.3.1 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.3.2 China National Pharmaceutical Group Corp Product Introduction, Application and Specification
        • 8.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 GlaxoSmithKline Plc
        • 8.4.1 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.4.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
        • 8.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Griffith University
        • 8.5.1 Griffith University Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.5.2 Griffith University Product Introduction, Application and Specification
        • 8.5.3 Griffith University Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 ImmunoBiology Ltd
        • 8.6.1 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.6.2 ImmunoBiology Ltd Product Introduction, Application and Specification
        • 8.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 JN-International Medical Corp
        • 8.7.1 JN-International Medical Corp Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.7.2 JN-International Medical Corp Product Introduction, Application and Specification
        • 8.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 MGB Biopharma Ltd
        • 8.8.1 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.8.2 MGB Biopharma Ltd Product Introduction, Application and Specification
        • 8.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Panacea Biotec Ltd
        • 8.9.1 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.9.2 Panacea Biotec Ltd Product Introduction, Application and Specification
        • 8.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Pfizer Inc
        • 8.10.1 Pfizer Inc Neisseria meningitidis Infections Drug Production Sites and Area Served
        • 8.10.2 Pfizer Inc Product Introduction, Application and Specification
        • 8.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Sanofi Pasteur SA
      • 8.12 Serum Institute of India Ltd
      • 8.13 Wellstat Vaccines LLC

      9 Development Trend of Analysis of Neisseria meningitidis Infections Drug Market

      • 9.1 Global Neisseria meningitidis Infections Drug Market Trend Analysis
        • 9.1.1 Global Neisseria meningitidis Infections Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Neisseria meningitidis Infections Drug Regional Market Trend
        • 9.2.1 North America Neisseria meningitidis Infections Drug Forecast 2019-2025
        • 9.2.2 Europe Neisseria meningitidis Infections Drug Forecast 2019-2025
        • 9.2.3 China Neisseria meningitidis Infections Drug Forecast 2019-2025
        • 9.2.4 Japan Neisseria meningitidis Infections Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Neisseria meningitidis Infections Drug Forecast 2019-2025
        • 9.2.6 India Neisseria meningitidis Infections Drug Forecast 2019-2025
      • 9.3 Neisseria meningitidis Infections Drug Market Trend (Product Type)
      • 9.4 Neisseria meningitidis Infections Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Neisseria meningitidis Infections Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Neisseria meningitidis Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Neisseria meningitidis Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neisseria meningitidis Infections Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Neisseria meningitidis Infections Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Neisseria meningitidis Infections Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Beijing Minhai Biotechnology Co Ltd
        Biological E Ltd
        China National Pharmaceutical Group Corp
        GlaxoSmithKline Plc
        Griffith University
        ImmunoBiology Ltd
        JN-International Medical Corp
        MGB Biopharma Ltd
        Panacea Biotec Ltd
        Pfizer Inc
        Sanofi Pasteur SA
        Serum Institute of India Ltd
        Wellstat Vaccines LLC

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        MGBBP-3
        NCL-195
        TP-10
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now